The Discounted Cash Flow (DCF) valuation of ScinoPharm Taiwan Ltd (1789.TW) is 10.20 TWD. With the latest stock price at 17.85 TWD, the upside of ScinoPharm Taiwan Ltd based on DCF is -42.9%.
Based on the latest price of 17.85 TWD and our DCF valuation, ScinoPharm Taiwan Ltd (1789.TW) is a sell. selling 1789.TW stocks now will result in a potential gain of 42.9%.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 7.4% | 6.2% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 8.36 - 16.15 | 10.20 |
| Upside | -53.1% - -9.5% | -42.9% |